Chronic neuropathic pain remains one of the most challenging conditions to treat, with current therapies offering limited benefit and being over-reliant on opioids. Researchers at Rensselaer Polytechnic Institute (RPI), along with collaborators from the University of Sydney and the University of Copenhagen, have developed an approach that offers a clearer path towards safer, non-addictive pain therapies.

The Jefferson Project at Chautauqua Lake is growing its environmental monitoring and modeling capabilities through a new partnership with the New York State Mesonet, bringing two advanced weather stations to Chatauqua Lake.

Jayashree Balaraman grew up in East Brunswick, New Jersey, the kind of student who loved biology and taught herself to code in high school because she was already beginning to sense that the two disciplines belonged together. When it came time to choose a college, RPI's emphasis on research and interdisciplinary thinking made it feel like the obvious fit. One visit to campus sealed the deal. 

Many disease-causing bacteria — including pathogens that can cause cholera, meningitis, and certain types of pneumonia — contain an enzyme called Na⁺-NQR. The enzyme is essentially a pump that helps bacteria generate energy by moving sodium ions across their cell membranes while transferring electrons.  

A team of researchers at RPI, in collaboration with the University of South Florida, University of North Carolina, and The Neural Stem Cell Institute, have made a discovery that opens the door to new treatments for Alzheimer’s disease and other brain disorders. 

RPI Biology Professor Doug Swank, Ph.D., was recently awarded the prestigious Marion J. Siegman Lectureship Award from the American Physiological Society. The award recognizes researchers who have made outstanding contributions to the understanding of muscle contraction and motility. 

The Shirley Ann Jackson, Ph.D. Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer Polytechnic Institute (RPI) was recently awarded $1 million in federal funds as part of the Congressionally Directed Spending program to advance RPI research and translational efforts related to pharmaceuticals, biopolymers, and food production. 

Research aims to address a critical bottleneck in the production of mRNA therapeutics.

This semester, the RPI-Mt. Sinai Center for Engineering and Precision Medicine (CEPM) welcomed the inaugural cohort of students in the center’s Ph.D. program in health sciences engineering jointly offered by RPI and Icahn School of Medicine at Mount Sinai.